The age at which large-breed dogs are spayed or neutered has become a hot topic with regard to obesity and nontraumatic orthopedic injuries, and a new study published July 17 in the journal PLOS ONE and based on data from the Morris Animal Foundation Golden Retriever Lifetime Study provides more information for veterinarians.
After receiving adverse reports involving five animals, Australia-based Jurox Animal Health voluntarily recalled two lots of the widely used intravenous injectable anesthetic Alfaxan unpreserved last week, according to the US Food and Drug Administration (FDA). The reason for the recall: The presence of aluminum phosphate precipitate, which, when injected, presents a possible risk of blood vessel inflammation and formation of potentially life-threatening blood clots.
According to Banfield Pet Hospital, pet obesity is an epidemic. But if it’s an epidemic, does that mean it’s a disease?
Most people know that the Veterinarian’s Oath focuses on caring for animals and protecting animal welfare. But there is also a very important line in the Oath: a newly minted veterinarian must also swear to benefit society through “the promotion of public health.”
When it comes to reopening a veterinary practice, “There’s no one-size-fits-all approach,” said veterinary epidemiologist J. Scott Weese.
The 2021 AAHA/AAFP Feline Life Stage Guidelines are here, and there’s plenty that's new.
Tamara Grubb, DVM, PhD, DACVAA, cochair of the 2020 AAHA Anesthesia and Monitoring Guidelines for Dogs and Cats , is excited about the new guidelines. “There are so many new things [that] I don’t even know where to start,” she told NEWStat .
Those two cats who tested positive for COVID-19 in New York State last month may have thrown a wrench in lab-test turnaround time for all the other cats.
In an effort to help veterinary practitioners elevate end-of-life care for companion animals, AAHA now offers an End-of-Life Care accreditation option for veterinary practices as part of the AAHA Standards of Accreditation .
Okay, maybe just one needle every three months. But one shot every 90 days sure beats daily insulin injections, if promising new research out of Purdue University bears fruit. Last week, the school released the preliminary findings of a new study: The first minimally invasive therapy to successfully reverse Type 1 diabetes within 24 hours and maintain insulin independence for at least 90 days in test subjects.